Page 48 - Read Online
P. 48

Page 10 of 13            Cangemi et al. Mini-invasive Surg 2022;6:3  https://dx.doi.org/10.20517/2574-1225.2021.99

               Financial support and sponsorship
               None.


               Conflicts of interest
               Aurigemma C, Burzotta F, Trani C received speaker’s fees from Abbott, Medtronic, and Abiomed. Other
               authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2022.

               REFERENCES
               1.       Iung B, Delgado V, Rosenhek R, et al; EORP VHD II Investigators. Contemporary presentation and management of valvular heart
                   disease: the Eurobservational research programme valvular heart disease II survey. Circulation 2019;140:1156-69.  DOI  PubMed
               2.       Stewart B, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease fn1fn1. J Am Coll Cardiol
                   1997;29:630-4.  DOI  PubMed
               3.       Yan AT, Koh M, Chan KK, et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis
                   study. J Am Coll Cardiol 2017;69:1523-32.  DOI  PubMed
               4.       Iung B. Interface between valve disease and ischaemic heart disease. Heart 2000;84:347-52.  DOI  PubMed  PMC
               5.       Auffret V, Lefevre T, Van Belle E, et al; FRANCE TAVI Investigators. Temporal trends in transcatheter aortic valve replacement in
                   France: France 2 to France TAVI. J Am Coll Cardiol 2017;70:42-55.  DOI  PubMed
               6.       Makkar RR, Fontana GP, Jilaihawi H, et al; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable
                   severe aortic stenosis. N Engl J Med 2012;366:1696-704.  DOI  PubMed
               7.       Kodali SK, Williams MR, Smith CR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-
                   valve replacement. N Engl J Med 2012;366:1686-95.  DOI  PubMed
               8.       Reardon MJ, Van Mieghem NM, Popma JJ, et al; SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in
                   intermediate-risk patients. N Engl J Med 2017;376:1321-31.  DOI  PubMed
               9.       Leon MB, Smith CR, Mack MJ, et al; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-
                   risk patients. N Engl J Med 2016;374:1609-20.  DOI  PubMed
               10.      Mack MJ, Leon MB, Thourani VH, et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-
                   expandable valve in low-risk patients. N Engl J Med 2019;380:1695-705.  DOI  PubMed
               11.      Popma JJ, Deeb GM, Yakubov SJ, et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-
                   expanding valve in low-risk patients. N Engl J Med 2019;380:1706-15.  DOI  PubMed
               12.      Saia F, Palmerini T, Compagnone M, et al. Coronary artery disease and reasonably incomplete coronary revascularization in high-risk
                   patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2020;95:19-27.  DOI  PubMed
               13.      Witberg G, Regev E, Chen S, et al. The prognostic effects of coronary disease severity and completeness of revascularization on
                   mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 2017;10:1428-35.  DOI  PubMed
               14.      Kleczynski P, Dziewierz A, Bagienski M, et al. Impact of coronary artery disease burden on 12-month mortality of patients after
                   transcatheter aortic valve implantation. J Interv Cardiol 2016;29:375-81.  DOI  PubMed
               15.      Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery
                   revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc 2017;6:e005960.  DOI  PubMed  PMC
               16.      Witberg G, Zusman O, Codner P, Assali A, Kornowski R. Impact of coronary artery revascularization completeness on outcomes of
                   patients with coronary artery disease undergoing transcatheter aortic valve replacement: a meta-analysis of studies using the residual
                   SYNTAX score (Synergy Between PCI With Taxus and Cardiac Surgery). Circ Cardiovasc Interv 2018;11:e006000.  DOI  PubMed
               17.      D'Ascenzo F, Verardi R, Visconti M, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation
                   on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention 2018;14:e1169-77.
                   DOI  PubMed
               18.      Tjang YS, van Hees Y, Körfer R, Grobbee DE, van der Heijden GJ. Predictors of mortality after aortic valve replacement. Eur J
                   Cardiothorac Surg 2007;32:469-74.  DOI  PubMed
               19.      Fujita B, Ensminger S, Bauer T, et al; GARY Executive Board. Trends in practice and outcomes from 2011 to 2015 for surgical aortic
                   valve replacement: an update from the German Aortic Valve Registry on 42776 patients. Eur J Cardiothorac Surg 2018;53:552-9.
                   DOI  PubMed
   43   44   45   46   47   48   49   50   51   52   53